{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:48:17Z","timestamp":1768286897646,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Technology Innovation Agency, South Africa"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["Innovation Doctoral Scholarship"],"award-info":[{"award-number":["Innovation Doctoral Scholarship"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Third World Women in Science Doctoral Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10534-016-9940-6","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T16:55:50Z","timestamp":1464713750000},"page":"637-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"29","author":[{"given":"Ntombenhle H.","family":"Gama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afag Y. F.","family":"Elkhadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna G.","family":"Gordhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bavesh D.","family":"Kana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Darkwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"9940_CR1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2174\/092986706776872970","volume":"13","author":"AS Abu-Surrah","year":"2006","unstructured":"Abu-Surrah AS, Kettunen M (2006) Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr Med Chem 13:1337\u20131357","journal-title":"Curr Med Chem"},{"key":"9940_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1107\/S0021889892010331","volume":"26","author":"A Altomore","year":"1993","unstructured":"Altomore A, Cascarano G, Giacovazzo C, Guagliardi A (1993) Completion and refinement of crystal structures with SIR92. J Appl Cryst 26:343\u2013350","journal-title":"J Appl Cryst"},{"key":"9940_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1087057111402825","volume":"16","author":"FA Atienzar","year":"2011","unstructured":"Atienzar FA, Tilmant K, Gerets HH et al (2011) The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models. J Biomol Screen 16:575\u2013587. doi: 10.1177\/1087057111402825","journal-title":"J Biomol Screen"},{"key":"9940_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/095632020201300305","volume":"13","author":"DE Bergstrom","year":"2002","unstructured":"Bergstrom DE, Lin X, Wood TD et al (2002) Polysulfonates derived from metal thiolate complexes as inhibitors of HIV-1 and various other enveloped viruses in vitro. Antivir Chem Chemother 13:185\u2013195","journal-title":"Antivir Chem Chemother"},{"key":"9940_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF03214741","volume":"29","author":"SL Best","year":"1996","unstructured":"Best SL, Sadler P (1996) Gold drugs: mechanism of Action and Toxicity. Gold Bull 29:87\u201393","journal-title":"Gold Bull"},{"key":"9940_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE et al (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749\u2013759. doi: 10.1084\/jem.20040874","journal-title":"J Exp Med"},{"key":"9940_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1039\/b208248a","volume":"1","author":"A Brik","year":"2003","unstructured":"Brik A, Wong C-H (2003) HIV-1 protease: mechanism and drug discovery. Org Biomol Chem 1:5\u201314","journal-title":"Org Biomol Chem"},{"key":"9940_CR8","volume-title":"APEX2, SADABS, & SAINT software reference manuals","author":"Bruker-AXS","year":"2009","unstructured":"Bruker-AXS (2009) APEX2, SADABS, & SAINT software reference manuals. Bruker-AXS, Madison"},{"key":"9940_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2006.05.021","volume":"71","author":"M-J Camarasa","year":"2006","unstructured":"Camarasa M-J, Vel\u00e1zquez S, San-F\u00e9lix A et al (2006) Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes? Antiviral Res 71:260\u2013267. doi: 10.1016\/j.antiviral.2006.05.021","journal-title":"Antiviral Res"},{"key":"9940_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cbpa.2009.11.015","volume":"14","author":"C Che","year":"2010","unstructured":"Che C, Siu F (2010) Metal complexes in medicine with a focus on enzyme inhibition. Curr Opin Chem Biol 14:255\u2013261. doi: 10.1016\/j.cbpa.2009.11.015","journal-title":"Curr Opin Chem Biol"},{"key":"9940_CR11","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1016\/j.ejmech.2010.07.057","volume":"45","author":"RA Souza De","year":"2010","unstructured":"De Souza RA, Stevanato A, Treu-filho O et al (2010) Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): x-ray structure of trans-[Pd(N3)2(isn)2]. Eur J Med Chem 45:4863\u20134868. doi: 10.1016\/j.ejmech.2010.07.057","journal-title":"Eur J Med Chem"},{"key":"9940_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1359-6446(96)10048-9","volume":"2","author":"GV De Lucca","year":"1997","unstructured":"De Lucca GV, Erickson-Viitanen S, Lam PYS (1997) Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule. Drug Discov Ther 2:6\u201318","journal-title":"Drug Discov Ther"},{"key":"9940_CR13","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","volume":"74","author":"CA Derdeyn","year":"2000","unstructured":"Derdeyn CA, Decker JM, Sfakianos JN et al (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74:8358\u20138367","journal-title":"J Virol"},{"key":"9940_CR14","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1128\/IAI.73.6.3492","volume":"73","author":"P Domenech","year":"2005","unstructured":"Domenech P, Reed MB, Iii CEB (2005) Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 73:3492\u20133501. doi: 10.1128\/IAI.73.6.3492","journal-title":"Infect Immun"},{"key":"9940_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1472-6882-14-77","volume":"14","author":"MS Ellithey","year":"2014","unstructured":"Ellithey MS, Lall N, Hussein AA, Meyer D (2014) Cytotoxic and HIV-1 enzyme inhibitory activities of Red Sea marine organisms. BMC Complement Altern Med 14:77. doi: 10.1186\/1472-6882-14-77","journal-title":"BMC Complement Altern Med"},{"key":"9940_CR16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/ja00342a024","volume":"105","author":"JP Farr","year":"1983","unstructured":"Farr JP, Olmstead MM et al (1983) Formation and reactivity of some heterobinuclear rhodium\/platinum complexes with 2-(diphenylphosphino)pyridine as a bridging ligand. J Am Chem Soc 105:792\u2013798","journal-title":"J Am Chem Soc"},{"key":"9940_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1107\/S0021889897003117","volume":"30","author":"L Farrugia","year":"1997","unstructured":"Farrugia L (1997) ORTEP-3 for windows\u2014a version of ORTEP-III with a graphical user interface (GUI). J Appl Crystallogr 30:565","journal-title":"J Appl Crystallogr"},{"key":"9940_CR18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","volume":"32","author":"L Farrugia","year":"1999","unstructured":"Farrugia L (1999) WinGX suite for small-molecule single-crystal crystallography. J Appl Crystallogr 32:837\u2013838","journal-title":"J Appl Crystallogr"},{"key":"9940_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/om900038u","author":"J Flapper","year":"2009","unstructured":"Flapper J, Kooijman H, Lutz M et al (2009) Nickel and palladium complexes of pyridine- phosphine ligands as ethene oligomerization catalysts. Organometallics. doi: 10.1021\/om900038u","journal-title":"Organometallics"},{"key":"9940_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1039\/b909036c","volume":"1","author":"P Fonteh","year":"2009","unstructured":"Fonteh P, Meyer D (2009) Novel gold(I) phosphine compounds inhibit HIV-1 enzymes. Metallomics 1:427\u2013433. doi: 10.1039\/b909036c","journal-title":"Metallomics"},{"key":"9940_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jinorgbio.2008.10.001","volume":"103","author":"PN Fonteh","year":"2009","unstructured":"Fonteh PN, Keter FK, Meyer D et al (2009) Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)-methane)gold(III) chloride: an HIV-1 reverse transcriptase and protease inhibitor. J Inorg Biochem 103:190\u2013194. doi: 10.1016\/j.jinorgbio.2008.10.001","journal-title":"J Inorg Biochem"},{"key":"9940_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.jinorgbio.2011.05.011","volume":"105","author":"PN Fonteh","year":"2011","unstructured":"Fonteh PN, Keter FK, Meyer D (2011) New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails. J Inorg Biochem 105:1173\u20131180. doi: 10.1016\/j.jinorgbio.2011.05.011","journal-title":"J Inorg Biochem"},{"key":"9940_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-015-9851-y","author":"P Fonteh","year":"2015","unstructured":"Fonteh P, Elkhadir A, Omindi B et al (2015) Impedance technology reveals correlations between cytotoxicity and lipophilicity of mono and bimetallic phosphine complexes. Biometals. doi: 10.1007\/s10534-015-9851-y","journal-title":"Biometals"},{"key":"9940_CR24","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1039\/b705551j","volume":"43","author":"SP Fricker","year":"2007","unstructured":"Fricker SP (2007) Metal based drugs: from serendipity to design. Dalton Trans 43:4903\u20134917. doi: 10.1039\/b705551j","journal-title":"Dalton Trans"},{"key":"9940_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi NR, Moll A, Sturm AW et al (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575\u20131580. doi: 10.1016\/S0140-6736(06)69573-1","journal-title":"Lancet"},{"key":"9940_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bcp.2009.07.023","volume":"79","author":"V Gandin","year":"2010","unstructured":"Gandin V, Potamitou A, Rigobello MP et al (2010) Cancer cell death induced by phosphine gold (I) compounds targeting thioredoxin reductase. Biochem Pharmacol 79:90\u2013101. doi: 10.1016\/j.bcp.2009.07.023","journal-title":"Biochem Pharmacol"},{"key":"9940_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0166-3542(99)00040-6","volume":"43","author":"Y Haraguchi","year":"1999","unstructured":"Haraguchi Y, Sakurai H, Hussain S et al (1999) Inhibition of HIV-1 infection by zinc group metal compounds. Antiviral Res 43:123\u2013133","journal-title":"Antiviral Res"},{"key":"9940_CR28","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1073\/pnas.88.13.5552","volume":"88","author":"AR Karlstrom","year":"1991","unstructured":"Karlstrom AR, Levine RL (1991) Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms. Proc Natl Acad Sci 88:5552\u20135556","journal-title":"Proc Natl Acad Sci"},{"key":"9940_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/rheumatology\/36.5.560","volume":"36","author":"WF Kean","year":"1997","unstructured":"Kean WF, Hart L, Buchanan WW et al (1997) Auranofin. Br J Rheumatol 36:560\u2013572","journal-title":"Br J Rheumatol"},{"key":"9940_CR30","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1016\/j.ejmech.2011.06.007","volume":"46","author":"H Khan","year":"2011","unstructured":"Khan H, Badshah A, Murtaz G et al (2011) Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes. Eur J Med Chem 46:4071\u20134077. doi: 10.1016\/j.ejmech.2011.06.007","journal-title":"Eur J Med Chem"},{"key":"9940_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.tiv.2012.08.019","volume":"27","author":"S Kustermann","year":"2013","unstructured":"Kustermann S, Boess F, Buness A et al (2013) A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects. Toxicol Vitr 27:1589\u20131595. doi: 10.1016\/j.tiv.2012.08.019","journal-title":"Toxicol Vitr"},{"key":"9940_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbpa.2012.01.006","volume":"16","author":"H Li","year":"2012","unstructured":"Li H, Sun H (2012) Recent advances in bioinorganic chemistry of bismuth. Curr Opin Chem Biol 16:74\u201383. doi: 10.1016\/j.cbpa.2012.01.006","journal-title":"Curr Opin Chem Biol"},{"key":"9940_CR33","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1111\/j.1742-4658.2012.08714.x","volume":"279","author":"M Li","year":"2012","unstructured":"Li M, Wlodawer A, Matu K (2012) Inhibition of XMRV and HIV-1 proteases by pepstatin A. FEBS J 279:3276\u20133286. doi: 10.1111\/j.1742-4658.2012.08714.x","journal-title":"FEBS J"},{"key":"9940_CR34","first-page":"505","volume-title":"Bioinorganic chemistry","author":"SJ Lippard","year":"1994","unstructured":"Lippard SJ (1994) Metals in Medicine. In: Bertini I, Gray HB, Lippard SJ, Valentine JS (eds) Bioinorganic chemistry. University Science Books, Carlifonia, pp 505\u2013583"},{"key":"9940_CR35","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1039\/b009117k","volume":"39","author":"J Liu","year":"2010","unstructured":"Liu J, Jacob C, Sheridan KJ et al (2010) The synthesis of, and characterization of the dynamic processes occurring in Pd(II) chelate complexes of 2-pyridyldiphenylphosphine. Dalton Trans 39:7921\u20137935. doi: 10.1039\/b009117k","journal-title":"Dalton Trans"},{"key":"9940_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0010-8545(02)00048-6","volume":"232","author":"MJ McKeage","year":"2002","unstructured":"McKeage MJ, Maharaj L, Berners-price SJ (2002) Mechanisms of cytotoxicity and antitumor activity of gold(I) phosphine complexes: the possible role of mitochondria. Coord Chem Rev 232:127\u2013135","journal-title":"Coord Chem Rev"},{"key":"9940_CR37","doi-asserted-by":"publisher","DOI":"10.1039\/b813568a","author":"E Meggers","year":"2009","unstructured":"Meggers E (2009) Targeting proteins with metal complexes. Chem Commun. doi: 10.1039\/b813568a","journal-title":"Chem Commun"},{"key":"9940_CR38","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos KD, Orvig C (2014) Metallodrugs in medicinal inorganic chemistry. Chem Rev 114:4540\u20134563","journal-title":"Chem Rev"},{"key":"9940_CR39","first-page":"229","volume":"170","author":"V Montessori","year":"2004","unstructured":"Montessori V, Press N, Harris M et al (2004) Adverse effects of antiretroviral therapy for HIV infection. CMAJ 170:229\u2013238","journal-title":"CMAJ"},{"key":"9940_CR40","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1016\/j.ejmech.2009.06.032","volume":"44","author":"AC Moro","year":"2009","unstructured":"Moro AC, Mauro AE, Netto AVG et al (2009) Antitumor and antimycobacterial activities of cyclopalladated complexes: x-ray structure of [Pd (C 2, N-dmba)(Br)(tu)] (dmba = N, N-dimethylbenzylamine, tu = thiourea). Eur J Med Chem 44:4611\u20134615. doi: 10.1016\/j.ejmech.2009.06.032","journal-title":"Eur J Med Chem"},{"key":"9940_CR41","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1128\/JVI.06893-11","volume":"86","author":"HT Mufhandu","year":"2012","unstructured":"Mufhandu HT, Gray ES, Madiga MC et al (2012) UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C. J Virol 86:4989\u20134999. doi: 10.1128\/JVI.06893-11","journal-title":"J Virol"},{"key":"9940_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep08824","volume":"5","author":"P Narayanasamy","year":"2015","unstructured":"Narayanasamy P, Switzer BL, Britigan BE (2015) Gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected macrophages. Sci Rep 5:1\u20137. doi: 10.1038\/srep08824","journal-title":"Sci Rep"},{"key":"9940_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/med","volume":"30","author":"S Nobili","year":"2009","unstructured":"Nobili S, Mini E, Landini I et al (2009) Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. Med Res Rev 30:550\u2013580. doi: 10.1002\/med","journal-title":"Med Res Rev"},{"key":"9940_CR44","first-page":"1","volume":"2013","author":"PL P\u00e1ez","year":"2013","unstructured":"P\u00e1ez PL, Baz\u00e1n CM, Bongiovanni ME et al (2013) Oxidative stress and antimicrobial activity of chromium (III) and ruthenium (II) complexes on Staphylococcus aureus and Escherichia coli. Biomed Res Int 2013:1\u20137","journal-title":"Biomed Res Int"},{"key":"9940_CR45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1107\/S0021889807029238","volume":"40","author":"L Palatinus","year":"2007","unstructured":"Palatinus L, Chapuis G (2007) SUPERFLIP- a computer program for the solution of crystal structures by charge flipping in arbitrary dimensions. J Appl Crystallogr 40:786\u2013790","journal-title":"J Appl Crystallogr"},{"key":"9940_CR46","first-page":"137","volume-title":"Understanding tuberculosis\u2014new approaches to fighting against drug resistance","author":"FR Pavan","year":"2012","unstructured":"Pavan FR, Sato DN, Leite CQF (2012) An approach to the search for new drugs against tuberculosis. In: Cardona P (ed) Understanding tuberculosis\u2014new approaches to fighting against drug resistance. InTech, Rijeka, pp 137\u2013146"},{"key":"9940_CR47","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.drudis.2007.08.001","volume":"12","author":"DJ Pepper","year":"2007","unstructured":"Pepper DJ, Meintjes GA, McIlleron H, Wilkinson RJ (2007) Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery. Drug Discov Today 12:980\u2013989. doi: 10.1016\/j.drudis.2007.08.001","journal-title":"Drug Discov Today"},{"key":"9940_CR48","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","volume":"72","author":"EJ Platt","year":"1998","unstructured":"Platt EJ, Wehrly K, Kuhmann SE et al (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72:2855\u20132864","journal-title":"J Virol"},{"key":"9940_CR49","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/JVI.00709-09","volume":"83","author":"EJ Platt","year":"2009","unstructured":"Platt EJ, Bilska M, Kozak SL et al (2009) Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Virol 83:8289\u20138292","journal-title":"J Virol"},{"key":"9940_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cct.2003.11.004","volume":"248","author":"AG Quiroga","year":"2004","unstructured":"Quiroga AG, Navarro Ranninger C (2004) Contribution to the SAR field of metallated and coordination complexes. Coord Chem Rev 248:119\u2013133. doi: 10.1016\/j.cct.2003.11.004","journal-title":"Coord Chem Rev"},{"key":"9940_CR51","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.ejmech.2009.12.073","volume":"45","author":"FV Rocha","year":"2010","unstructured":"Rocha FV, Barra CV, Netto AVG et al (2010) 3, 5-Dimethyl-1-thiocarbamoylpyrazole and its Pd (II) complexes: synthesis, spectral studies and antitumor activity. Eur J Med Chem 45:1698\u20131702. doi: 10.1016\/j.ejmech.2009.12.073","journal-title":"Eur J Med Chem"},{"key":"9940_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0020-1693(00)82025-3","volume":"169","author":"R R\u00fclke","year":"1990","unstructured":"R\u00fclke R, Han I, Elsevier C et al (1990) New neutral and cationic methylpalladium (II) complexes containing tridentate nitrogen ligands. Synthesis, reactivity and x-ray crystal structure of {\u03c3-N-2-(N-isopropylcarbaldimino)-6-(N-isopropylcarbaldimino)-\u03c3-N-pyridyl}(chloro) methylpalladium (II) and [{\u03c3 3-N, N\u2032, N\u2033-2, 2\u2032: 6\u2032, 2\u2033-terpyridyl} methylpalladium (II)] chloride dihydrate. Inorg Chim Acta 169:5\u20138","journal-title":"Inorg Chim Acta"},{"key":"9940_CR53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1351\/pac199870040863","volume":"70","author":"PJ Sadler","year":"1998","unstructured":"Sadler PJ, Guo Z (1998) Metal complexes in medicine: design and mechanism of action. Pure Appl Chem 70:863\u2013871. doi: 10.1351\/pac199870040863","journal-title":"Pure Appl Chem"},{"key":"9940_CR54","first-page":"2861","volume":"4","author":"P Sevillano","year":"1999","unstructured":"Sevillano P, Habtemariam A, Parsons S et al (1999) Gold (I)-induced chelate ring-opening of palladium(II) and platinum (II) triphos complexes. J Chem Soc 4:2861\u20132870","journal-title":"J Chem Soc"},{"key":"9940_CR55","first-page":"1818","volume":"41","author":"DL Shapiro","year":"1996","unstructured":"Shapiro DL, Masci JR (1996) Treatment of rheumatoid arthritis with gold. J Rheumatol 41:1818\u20131820","journal-title":"J Rheumatol"},{"key":"9940_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"GM Sheldrick","year":"2008","unstructured":"Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr 64:112\u2013122","journal-title":"Acta Crystallogr"},{"key":"9940_CR57","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","volume":"82","author":"Y Takeuchi","year":"2008","unstructured":"Takeuchi Y, McClure MO, Pizzato M (2008) Identification of \u03b3-retroviruses constitutively released from cell lines used for HIV research. J Virol 82:12585\u201312588","journal-title":"J Virol"},{"key":"9940_CR58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(12)70098-4","volume":"11","author":"IL Tan","year":"2012","unstructured":"Tan IL, Smith BR, Von Geldern G et al (2012) HIV-associated opportunistic infections of the CNS. Lancet Neurol 11:605\u2013617. doi: 10.1016\/S1474-4422(12)70098-4","journal-title":"Lancet Neurol"},{"key":"9940_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/zaac.19744060102","volume":"406","author":"E Uhlig","year":"1974","unstructured":"Uhlig E, Keiser S (1974) Palladium(II)-Komplexe des \u03b2-(diphenylphosphino)-\u00e4thylpyridins-(2) und des \u03b2-(Diphenylarsino)-\u00e4thylpyridins-(2). Zeitschrift f\u00fcr Anorg und Allg Chemie 406:1\u20136. doi: 10.1002\/zaac.19744060102","journal-title":"Zeitschrift f\u00fcr Anorg und Allg Chemie"},{"key":"9940_CR60","first-page":"708","volume":"13","author":"R Asslet Van","year":"1994","unstructured":"Van Asslet R, Rijnberg E, Elsevier C (1994) Rigid bidentate nitrogen ligands in organometallic chemistry and homogeneous catalysis. Stabilization of high oxidation states by rigid bidentate nitrogen ligands: synthesis and characterization of diorgano- and triorganoPd(IV) and cationic triorganoPt(IV). Organometallics 13:708","journal-title":"Organometallics"},{"key":"9940_CR61","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei X, Decker J, Liu H et al (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46:1896\u20131905. doi: 10.1128\/AAC.46.6.1896","journal-title":"Antimicrob Agents Chemother"},{"key":"9940_CR62","unstructured":"WHO (2014) Global TB fact sheet. Accessed 23 Dec 2014"},{"key":"9940_CR63","first-page":"303","volume":"6","author":"G Xinxin","year":"1992","unstructured":"Xinxin G, Weijun Z, Shuji Z et al (1992) The synthesis of complexes of 2-(diphenylphosphino)pyridine with nickel, cobalt, palladium, iron and their catalytic activity for the carbonylation of ethanol to ethyl propionate. J Mol Catal 6:303","journal-title":"J Mol Catal"},{"key":"9940_CR64","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0960-894X(00)00369-3","volume":"10","author":"R Zutshi","year":"2000","unstructured":"Zutshi R, Chmielewski J (2000) Targeting the dimerization interface for irreversible inhibition of HIV-1 protease. Bioorg Med Chem Lett 10:1901\u20131903","journal-title":"Bioorg Med Chem Lett"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-016-9940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-016-9940-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-016-9940-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T10:45:50Z","timestamp":1600685150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-016-9940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9940"],"URL":"https:\/\/doi.org\/10.1007\/s10534-016-9940-6","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}